# US 2021/0174897 A1 · Method for generating frequency distribution of background allele in sequencing data obtained from acellular nucleic acid, and method for detecting mutation from acellular nucleic acid using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0174897 A1
- Document ID: US20210174897A1
- Status: Published application
- Kind: A1
- Application number: 16/616,773
- Filed: 2018-04-17
- Published: 2021-06-10
- Earliest claimed: 2017-05-24
- Assignees: Geninus Inc.
- Applicants: Geninus Inc.
- Inventors: Woong Yang PARK; Dong Hyun PARK; Dae Soon SON
- Web page: https://patentgrep.com/patent/US20210174897A1

## CPC

- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- C12Q 1/68: involving nucleic acids
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B 40/10: Signal processing, e.g. from mass spectrometry [MS] or from PCR
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided are a method for generating a distribution of background allele frequency in sequencing data obtained from a cell-free nucleic acid, a frequency distribution matrix of background alleles obtained by the method, and a method of detecting a variation in the cell-free nucleic acid using the matrix. According to the method, to remove germline variations, sequencing data of a nucleic acid isolated from a cell of a test subject itself may be used to generate a distribution of background allele frequency in the sequencing data obtained from the cell-free nucleic acid, and thus there are advantages in terms of reducing costs and time.

## Claims

### Claim 1

A method of generating a distribution of background allele frequency in sequencing data obtained from a cell-free nucleic acid, comprising:
obtaining first sequencing data of one or more positions on a chromosome from the cell-free nucleic acid;
obtaining second sequencing data of one or more positions on the chromosome from a nucleic acid isolated from a cell;
generating a distribution of background allele frequency at one or more positions on the chromosome, based on the second sequencing data; and
estimating the distribution of background allele frequency in the first sequencing data using the distribution of background allele frequency.

### Claim 2 (depends on 1)

The method of claim 1, comprising performing fragmentation of the nucleic acid isolated from the cell, prior to obtaining the second sequencing data.

### Claim 3 (depends on 2)

The method of claim 2, wherein the fragmentation is physical, chemical, thermal, optical, ultrasonic, or enzymatic cleavage of the nucleic acid isolated from the cell.

### Claim 4 (depends on 3)

The method of claim 3, wherein the ultrasonic cleavage is applying ultrasonic waves at 50 W to 160 W for 10 seconds to 300 seconds.

### Claim 5 (depends on 2)

The method of claim 2, wherein the sizes of the fragmented nucleic acids are 200 bp or more.

### Claim 6 (depends on 1)

The method of claim 1, wherein the nucleic acid isolated from the cell and the cell-free nucleic acid are derived from the same subject or different subjects.

### Claim 7 (depends on 1)

The method of claim 1, wherein the nucleic acid isolated from the cell is isolated from a blood cell, an oral epithelial cell, a hair follicle cell, a skin fibroblast, or a combination thereof.

### Claim 8 (depends on 1)

The method of claim 1, wherein the cell-free nucleic acid is present in blood, plasma, serum, urine, saliva, mucous secretions, sputum, feces, tears, or a combination thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the cell-free nucleic acid is a circulating tumor nucleic acid.

### Claim 10

A frequency distribution matrix of background alleles in sequencing data obtained from a cell-free nucleic acid, generated by:
obtaining first sequencing data of one or more positions on a chromosome from the cell-free nucleic acid;
obtaining second sequencing data of one or more positions on the chromosome from a nucleic acid isolated from a cell;
generating a distribution of background allele frequency at one or more positions on the chromosome, based on the second sequencing data; and
estimating the distribution of background allele frequency in the first sequencing data using the distribution of background allele frequency.

### Claim 11

A method of detecting a variation in a cell-free nucleic acid, comprising:
obtaining first sequencing data of one or more positions on a chromosome from the cell-free nucleic acid;
obtaining second sequencing data of one or more positions on the chromosome from a nucleic acid isolated from a cell;
generating a distribution of background allele frequency at one or more positions on the chromosome, based on the second sequencing data; and
detecting variations by comparing any allele frequency at one or more positions on the chromosome in the first sequencing data with the distribution of background allele frequency at positions corresponding thereto.

### Claim 12 (depends on 11)

The method of claim 11, comprising:
determining that the allele is a significant variant when any allele frequency at one or more positions on the chromosome in the first sequencing data is larger than the distribution of background allele frequency at the positions corresponding thereto; and
determining that the allele is not a significant variant when any allele frequency at one or more positions on the chromosome in the first sequencing data is smaller than or equal to the distribution of background allele frequency at the positions corresponding thereto.
